Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths Re-transplant Lost to follow up Functioning graft at 31 st December * 1 patient who was alive until 05/12/1997 is recorded died with missing date of death ** 1 patient transplanted in 2003 is recorded as death with missing date of death Figure 4.1.1: Stock and Flow of Liver Transplantation,

Table 4.1.2: Distribution of Patients by Place of Transplant, Year TOTAL No. Local Overseas TOTAL Table 4.1.3: Distribution of Patients by Centres for Liver Transplantation, Year TOTAL CentreNo. Sime Darby Medical Centre Hospital Selayang Australia National University Hospital, Singapore Kings College Hospital, UK Tianjin, China Asian Centre for Liver Disease, Singapore * 4 TOTAL * Data was not reported Table 4.1.4: Distribution of Transplant Recipients by Follow-up Centres, 2007 CentreNo.% Number of patient with functioning graft at 31 st December Kuala Lumpur Hospital24 Sime Darby Medical Centre2748 Selayang Hospital2341 Singapore12 Univeristy of Malaya Medical Centre35

Table 4.2.1: Distribution of Patients by Gender, Year TOTAL Gender No. Male Female TOTAL Figure 4.2.1: Distribution of Patients by Gender,

Table 4.2.2: Distribution of Patients by Ethnic Group, Year TOTAL Ethnic group No. Malay Chinese Indian Others TOTAL Figure 4.2.2: Distribution of Patients by Ethnic Group,

Table 4.2.3: Distribution of Patient by Age, * Age=date of transplant – date of birth

Table 4.2.4: Primary Diagnosis, (N=95) Table 4.2.5: Indication for Transplantation, (N=95) Note : 6 patients have more than one primary disease Note : 28 patients had 1 indication for transplantation, 63 had more than 1 indication for transplantation

Table 4.2.6: Recipient Blood Group, (N=95) Year Blood groupNo. A B AB O No data TOTAL Year TOTAL Blood groupNo. A B AB O No data TOTAL

Table : Distribution of Patients by Type of Donors, (N=95) Table : Immunosuppressive Drug Treatment at Transplantation, (N=95)

Table 4.4.1: Patient Survival by Year of Transplant, (N=95) Year of Transplant Interval (months)% SurvivalSE% SurvivalSE Figure 4.4.1: Patient Survival by Year of Transplant, SE=standard error

Table 4.4.2: Patient Survival by Gender, (N=95) GenderMaleFemale Interval (months)% SurvivalSE% SurvivalSE Figure 4.4.2: Patient Survival by Gender, SE=standard error

≥10 years Table 4.4.3: Patient Survival by Age Group, (N=95) Age group0-9 years≥10 years Interval (months)% SurvivalSE% SurvivalSE Figure 4.4.3: Patient Survival by Age Group, SE=standard error

Table 4.4.4: Distribution of Patient by Cause of Death, (N=95)